Skip to content
10-Q

Quarterly Report

CABALETTA BIO, INC. CABA

0001759138-26-000026

← back to feed
Filed
May 14, 2026 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2026 · May 7, 2026 163.05M sh
Shares Diluted Q1 2026 · Mar 31, 2026 112.03M sh
Shares Diluted Q1 2026 · Mar 31, 2025 50.74M sh
Capex Q1 2026 · Mar 31, 2026 $0
Capex Q1 2026 · Mar 31, 2025 $785K
Operating Cash Flow Q1 2026 · Mar 31, 2026 −$42.56M
Operating Cash Flow Q1 2026 · Mar 31, 2025 −$30.8M
Short Term Investments Q1 2026 · Mar 31, 2026 $0
Short Term Investments Q1 2026 · Dec 31, 2025 $50.62M
Cash And Equivalents Q1 2026 · Mar 31, 2026 $116.64M
Cash And Equivalents Q1 2026 · Dec 31, 2025 $82.98M
Stockholders Equity Q1 2026 · Mar 31, 2026 $103.31M
Stockholders Equity Q1 2026 · Dec 31, 2025 $112.05M
Stockholders Equity Q1 2026 · Mar 31, 2025 $121.55M
Stockholders Equity Q1 2026 · Dec 31, 2024 $152.34M
Current Liabilities Q1 2026 · Mar 31, 2026 $41.51M
Current Liabilities Q1 2026 · Dec 31, 2025 $50.15M
Total Liabilities Q1 2026 · Mar 31, 2026 $44.84M
Total Liabilities Q1 2026 · Dec 31, 2025 $53.03M
Current Assets Q1 2026 · Mar 31, 2026 $122.32M
Current Assets Q1 2026 · Dec 31, 2025 $138.87M
Total Assets Q1 2026 · Mar 31, 2026 $148.15M
Total Assets Q1 2026 · Dec 31, 2025 $165.08M
Eps Diluted Q1 2026 · Mar 31, 2026 −$0.39
Eps Diluted Q1 2026 · Mar 31, 2025 −$0.71
Eps Basic Q1 2026 · Mar 31, 2026 −$0.39
Eps Basic Q1 2026 · Mar 31, 2025 −$0.71
Sga Expense Q1 2026 · Mar 31, 2026 $6.94M
Sga Expense Q1 2026 · Mar 31, 2025 $8.12M
Rd Expense Q1 2026 · Mar 31, 2026 $37.35M
Rd Expense Q1 2026 · Mar 31, 2025 $29.02M
Net Income Q1 2026 · Mar 31, 2026 −$43.52M
Net Income Q1 2026 · Mar 31, 2025 −$35.94M
Operating Income Q1 2026 · Mar 31, 2026 −$44.3M
Operating Income Q1 2026 · Mar 31, 2025 −$37.14M